Effect of Daily Short Message System (SMS) Reminders on Medication Adherence to Oral Antipsychotics in Patients With Schizophrenia

Completed

• Conditions: Schizophrenia

• Registration Number: NCT00873249
• Lead Sponsor: AstraZeneca

Brief Summary

This study is a 6-month, multicenter, randomized study to assess the effect of daily SMS reminders sent during 3 months in the adherence to oral antipsychotic treatment in stabilized outpatients with schizophrenia.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2009-03-31
• Study First Submitted QC: 2009-03-31
• Study Start: 2009-04
• Study First Posted: 2009-04-01
• Status Verified: 2010-03
• Primary Completion: 2010-03
• Study Completion: 2010-03
• Last Update Submitted: 2010-03-23
• Last Update Posted: 2010-03-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 339

Inclusion Criteria

• Male or female patients older than 18 years
• With a diagnosis of schizophrenia (DSM-IV TR criteria)
• Stabilized out-patients
• Under oral antipsychotic monotherapy

Exclusion Criteria

• Administration of a depot antipsychotic drug
• Suicide risk

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Morisky Green Questionnaire	baseline, at months 3 and 6

Secondary Outcome Measures

Name	Time	Method
Clinical Global Impression- Schizophrenia (CGI-SCH)	baseline, at months 3 and 6
Register of Adherence to Treatment (RAT)	baseline, at months 3 and 6

Trial Locations

Locations (1)

Research Site; 🇪🇸 Zamora, Spain